Ronald Nahass

7.2k total citations
61 papers, 1.4k citations indexed

About

Ronald Nahass is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Ronald Nahass has authored 61 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Epidemiology, 27 papers in Hepatology and 19 papers in Infectious Diseases. Recurrent topics in Ronald Nahass's work include Hepatitis C virus research (27 papers), Hepatitis B Virus Studies (17 papers) and Liver Disease Diagnosis and Treatment (15 papers). Ronald Nahass is often cited by papers focused on Hepatitis C virus research (27 papers), Hepatitis B Virus Studies (17 papers) and Liver Disease Diagnosis and Treatment (15 papers). Ronald Nahass collaborates with scholars based in United States, New Zealand and Netherlands. Ronald Nahass's co-authors include Luigi Brunetti, David J. Gocke, Michael P. Weinstein, Joachim Bartels, John G. McHutchison, Lawrence Martinelli, Russell M. Petrak, Daniel P. McQuillen, Diana M. Brainard and Mitchell Davis and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

Ronald Nahass

58 papers receiving 1.4k citations

Peers

Ronald Nahass
Javier Murillas Spain
Hae Suk Cheong South Korea
Matilde Sánchez‐Conde Spain
Cristina Gervasoni Italy
Nicola D. Thompson United States
Jean-Pierre Sollet France
Andrew A. Quartin United States
Mauro Codeluppi Italy
Hla‐Hla Thein Canada
Firouzé Bani‐Sadr France
Javier Murillas Spain
Ronald Nahass
Citations per year, relative to Ronald Nahass Ronald Nahass (= 1×) peers Javier Murillas

Countries citing papers authored by Ronald Nahass

Since Specialization
Citations

This map shows the geographic impact of Ronald Nahass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald Nahass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald Nahass more than expected).

Fields of papers citing papers by Ronald Nahass

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald Nahass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald Nahass. The network helps show where Ronald Nahass may publish in the future.

Co-authorship network of co-authors of Ronald Nahass

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald Nahass. A scholar is included among the top collaborators of Ronald Nahass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald Nahass. Ronald Nahass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Colson, Amy E., Peter Ruane, Moti Ramgopal, et al.. (2025). 577. Week 48 Results of a Phase 2 Study Evaluating Once-weekly Oral Islatravir Plus Lenacapavir. Open Forum Infectious Diseases. 12(Supplement_1). 2 indexed citations
2.
Liu, Yongzhen, et al.. (2024). Development of a dual channel detection system for pan-genotypic simultaneous quantification of hepatitis B and delta viruses. Emerging Microbes & Infections. 13(1). 2350167–2350167.
3.
4.
Brunetti, Luigi, Hélène Chapy, Ronald Nahass, et al.. (2023). Relationship between Body Composition and Serum Immunoglobulin Concentrations after Administration of Intravenous Immune Globulin–Preclinical and Clinical Evidence. Pharmaceutics. 15(2). 510–510. 2 indexed citations
5.
Turgeon, Jacques, et al.. (2023). The Association of Serotonin Toxicity with Combination Linezolid–Serotonergic Agent Therapy: A Systematic Review and Meta-Analysis. SHILAP Revista de lepidopterología. 11(6). 182–182. 2 indexed citations
6.
Nahass, Ronald, et al.. (2023). Successful Treatment of Cutibacterium acnes Prosthetic Joint Infection With Single-Stage Exchange and Oral Antibiotics. Open Forum Infectious Diseases. 10(8). ofad370–ofad370. 1 indexed citations
7.
Dalgård, Olav, Alain H. Litwin, Oren Shibolet, et al.. (2022). Health-related quality of life in people receiving opioid agonist treatment and treatment for hepatitis C virus infection. Journal of Addictive Diseases. 41(3). 213–224. 3 indexed citations
8.
Tsai, Andrew, et al.. (2020). Impact of tocilizumab administration on mortality in severe COVID-19. Scientific Reports. 10(1). 19131–19131. 42 indexed citations
9.
Eby, Joshua C., Michael Lane, Michael A. Horberg, et al.. (2018). How Do You Measure Up: Quality Measurement for Improving Patient Care and Establishing the Value of Infectious Diseases Specialists. Clinical Infectious Diseases. 68(11). 1946–1951. 5 indexed citations
10.
Brunetti, Luigi, et al.. (2018). The risk of cardiac events in patients who received concomitant levofloxacin and amiodarone. International Journal of Infectious Diseases. 78. 50–56. 7 indexed citations
11.
Nahass, Ronald, et al.. (2016). Linkage to Care for Suburban Heroin Users with Hepatitis C Virus Infection, New Jersey, USA. Emerging infectious diseases. 22(5). 907–909. 19 indexed citations
12.
Kwo, Paul Y., Norman Gitlin, Ronald Nahass, et al.. (2016). Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study. PMC. 5 indexed citations
13.
Everson, Gregory T., William Towner, Mitchell Davis, et al.. (2015). Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection. Annals of Internal Medicine. 4 indexed citations
14.
Brunetti, Luigi, Leonid Kagan, Lauren M. Aleksunes, et al.. (2015). Cefoxitin Plasma and Subcutaneous Adipose Tissue Concentration in Patients Undergoing Sleeve Gastrectomy. Clinical Therapeutics. 38(1). 204–210. 11 indexed citations
15.
16.
Nahass, Ronald. (2014). The Infectious Diseases Physician in the Future of Healthcare: Not Only About Antibiotic Prescribing. Clinical Infectious Diseases. 60(5). 773–776. 6 indexed citations
17.
Schmitt, Steven, Daniel P. McQuillen, Ronald Nahass, et al.. (2013). Infectious Diseases Specialty Intervention Is Associated With Decreased Mortality and Lower Healthcare Costs. Clinical Infectious Diseases. 58(1). 22–28. 141 indexed citations
18.
McQuillen, Daniel P., et al.. (2008). The Value of Infectious Diseases Specialists: Non–Patient Care Activities. Clinical Infectious Diseases. 47(8). 1051–1063. 63 indexed citations
19.
Nahass, Ronald, et al.. (1995). Vertebral Osteomyelitis Due to Roseomonas Species: Case Report and Review of the Evaluation of Vertebral Osteomyelitis. Clinical Infectious Diseases. 21(6). 1474–1476. 24 indexed citations
20.
Nahass, Ronald & David J. Gocke. (1988). Toxic shock syndrome associated with use of a nasal tampon. The American Journal of Medicine. 84(3). 629–631. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Javier Murillas Breakdown of academic impact, for papers by Hae Suk Cheong Breakdown of academic impact, for papers by Matilde Sánchez‐Conde Breakdown of academic impact, for papers by Cristina Gervasoni Breakdown of academic impact, for papers by Nicola D. Thompson Breakdown of academic impact, for papers by Jean-Pierre Sollet Breakdown of academic impact, for papers by Andrew A. Quartin Breakdown of academic impact, for papers by Mauro Codeluppi Breakdown of academic impact, for papers by Hla‐Hla Thein Breakdown of academic impact, for papers by Firouzé Bani‐Sadr
Rankless by CCL
2026